De meest recente tweets over Merck & Co (NYSE notering: MRK):
Short sale volume (not short interest) for $MRK on 2023-03-27 is 53%. https://t.co/3fSg8Keh0Q $BMY 47% $NVS 55% $JNJ 48% $LLY 56%
(ongeveer 3 seconde geleden)
ALERTS ☑️ DAILY UPDATE ☑️ WATCHLIST ☑️ JOIN OUR DISCORD 👇👇 https://t.co/NINXxMSIEd $NIO $BA $TSLA $SPY $AMD $PT $EV… https://t.co/t1Qjdv3zYR
(ongeveer 43 minuten geleden)
$mrk *Top analyst price target for next week..📈📉🚀 https://t.co/3c4aRiKn67
(ongeveer 47 minuten geleden)
RT @BertrandBio: $MRK Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer | NEJM https://t.co/8LvOi7IVAJ https://t.co/1E6TzQDI0g
(ongeveer 1 uur geleden)
$mrk *Top analyst price target for next week..📈📉🚀 https://t.co/9BNmzY5X7r
(ongeveer 1 uur geleden)
$mrk Top analyst target price for next week >💸 💰> 🔗https://t.co/dHQkeVTy9o
(ongeveer 1 uur geleden)
$MRK #Cancer @tqlagirl @GCompounder 👇 https://t.co/fKUNjqtDyS https://t.co/w10AEStEKY
(ongeveer 1 uur geleden)
RT @buyingincome: $SCHD Top 10 Dividend Increases 📲 $VZ 2.0% 🥤 $KO 4.6% ✈️ $LMT 7.1% 💽 $TXN 7.8% 🖥️ $IBM 0.6% 🏡 $HD 10.0% 🥼 $MRK 5.8% 🧋 $…
(ongeveer 1 uur geleden)
RT @FRONTPAGEARMY2: $NICH @nitchescorp developed the NITCHES (Ownership Verification System) App to prove the authenticity of its exclusive…
(ongeveer 2 uren geleden)
$MRK: Merck's KEYTRUDA (pembrolizumab) plus chemotherapy significantly improved progression-free survival compared.… https://t.co/G2a9VFLGno
(ongeveer 2 uren geleden)
RT @DividendTalks: 🩺🥼Favourite Healthcare Stock🥼🩺 $MPW Medical Properties Trust - 16% Yield $PFE Pfizer Inc - 4.1% Yield $ABBV AbbVie In…
(ongeveer 2 uren geleden)
$MRK - Merck's Keytruda successful in multiple types of endometrial cancer https://t.co/Hyc2bOGnCm
(ongeveer 3 uren geleden)
$MRK Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer | NEJM https://t.co/8LvOi7IVAJ https://t.co/1E6TzQDI0g
(ongeveer 3 uren geleden)
Biggest Mega-Cap Gainers for Mar 27, 2023: $BAC +4.97% $JPM +2.87% $ORCL +2.42% $XOM +2.19% $MRK +2.03% $WMT +1.67… https://t.co/vVFepsuXTe
(ongeveer 3 uren geleden)
【🇺🇸時価総額上位銘柄トレンド】 $AAPL $MSFT $GOOG $AMZN $TSLA $BRK.B $META $JNJ $T $NVDA $KO $XOM $WMT $PG $JPM $V $MA $HD $UNH… https://t.co/9qQfLxIFgx
(ongeveer 3 uren geleden)
RT @BullBearBres: Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer https://t.co/wfeLF3KRu1 $MRK 🇺🇸 Merck https://t.co/lMuMb…
(ongeveer 3 uren geleden)
RT @BullBearBres: $MRK 🇺🇸 Merck KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Progression-Free Survival Compared to C…
(ongeveer 3 uren geleden)
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer https://t.co/wfeLF3KRu1 $MRK 🇺🇸 Merck https://t.co/lMuMbsnE2k
(ongeveer 3 uren geleden)
$MRK 🇺🇸 Merck KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Progression-Free Survival Compare… https://t.co/NIYP6D9HT9
(ongeveer 4 uren geleden)